Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Otsuka Pharmaceutical Co Ltdannounces that it has completed the acquisition of Jnana Therapeutics Inc Jnana based in Boston Massachusetts Jnana has become a direct subsidiary of Otsuka America Inc OAI which is a fully owned subsidiary of Otsuka
Telix and RLS USA Inc Americas only Joint Commissionaccredited radiopharmacy network distributing PET SPECT and therapeutic radiopharmaceuticals today announced an agreement by the Company to acquire RLS from its parent company RLS Group Ltd The acqu...
Shanghai Henlius Biotech Incannounced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA issued a positive opinion recommending approval of HANSIZHUANG serplulimab Henlius independently developed antiPD...
Regeneron Pharmaceuticals Incand Sanofi today announced that the European Medicines Agencys Committee for Medicinal Products for Human Use CHMP adopted a positive opinion recommending the expanded approval of Dupixent dupilumab in the European Union...
CD Suzhou Biopharma has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application of CD entering a Phase I firstinhuman trial
InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases announced today the approval of the Investigational New Drug to conduct the clinical trial of Bcell lymphoma BCL inhibitor ICP in combinat...
Lifecore Biomedical Inca fully integrated contract development and manufacturing organizationtoday announced that the companys recently installed highspeed multipurpose head isolator filler is GMPready and operational Lifecore is now positioned to of...
Amplia Therapeutics Limited is pleased to announce that the United States Food and Drug Administration FDA has granted Fast Track Designation to Amplias Focal Adhesion Kinase inhibitor narmafotinib for the treatment of advanced pancreatic cancer
Galmed Pharmaceuticals Ltd a clinicalstage biopharmaceutical company for fibroinflammatory indications announced today that based on the recently published results from the OpenLabel part of its Phase NASH study new scientific publications on the ro...
Roche announced today positive topline results of the phase III CENTERSTONE study of Xofluza an antiviral showing a reduction in the transmission of influenza viruses The study met its primary endpoint demonstrating that a single oral dose of Xofluza...
